Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000690894 | SCV000818623 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000730780 | SCV000858543 | uncertain significance | not provided | 2017-12-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000730780 | SCV003829308 | uncertain significance | not provided | 2019-04-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004601244 | SCV005098309 | uncertain significance | Inborn genetic diseases | 2024-04-23 | criteria provided, single submitter | clinical testing | The c.1546A>G (p.M516V) alteration is located in exon 15 (coding exon 13) of the CC2D2A gene. This alteration results from a A to G substitution at nucleotide position 1546, causing the methionine (M) at amino acid position 516 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |